Equity award and tax withholding reported by HNI (HNI) executive Roch
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
HNI CORP executive Michael J. Roch reported equity compensation activity involving the company’s common stock. He received a grant or award of 5,392 shares at $0.0000 per share, increasing his direct holdings to 25,429 shares immediately after that acquisition.
On the same date, 1,661 shares were disposed of at $50.1400 per share to satisfy tax withholding obligations related to previously granted performance stock units that vested on February 25, 2026. The footnotes clarify these shares were withheld by the issuer and that no shares were sold on the open market, leaving him with 23,768 directly owned shares following the tax-withholding disposition.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Roch Michael J.
Role
CCO, WP & Health, Kimball Intl
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,392 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,661 | $50.14 | $83K |
Holdings After Transaction:
Common Stock — 25,429 shares (Direct)
Footnotes (1)
- Reflects shares of Common Stock of Issuer with respect to Performance Stock Units granted under Issuer's 2017 Stock-Based Compensation Plan on February 15, 2023. These shares were withheld by Issuer to cover taxes upon vesting of Performance Stock Units that vested on February 25, 2026. No shares were sold.
FAQ
What insider transactions did HNI (HNI) executive Michael J. Roch report?
Michael J. Roch reported one equity award and one tax-withholding disposition. He received 5,392 HNI common shares as a grant and had 1,661 shares withheld by the issuer to cover taxes on vested performance stock units.
What type of equity award did HNI (HNI) grant in this Form 4?
The Form 4 reflects shares associated with performance stock units granted under HNI’s 2017 Stock-Based Compensation Plan on February 15, 2023. The 5,392 shares reported were acquired as a grant or award at a stated price of $0.0000 per share.